Todd Baumgartner

Todd Baumgartner, M.D., M.P.H., is senior vice president of Global Regulatory Affairs, Pharmacovigilance and Biometrics at Ovid. Dr. Baumgartner brings extensive industry experience from both large pharmaceuticals and small biotechs across multiple functional areas, including development, regulatory and operations. Prior to joining Ovid, Dr. Baumgartner was at Acorda Therapeutics (NASDAQ: ACOR), where he led the regulatory and clinical operations functions, ultimately serving as senior vice president of Regulatory Affairs. During his time at Acorda, he led the successful regulatory strategy for Inbrija® (levodopa inhalation powder) for Parkinson’s OFF episodes, which resulted in an NDA submission in the United States and a MAA submission in Europe, with subsequent approvals in both regions. Prior to Acorda, Dr. Baumgartner was at Purdue Pharma, first as vice president of Regulatory Affairs leading the regulatory, pharmacovigilance and quality teams, and then as chief medical officer, where he led a team of more than 300 responsible for all of Purdue’s drug development, medical and scientific functions. During this time, he led the NDA filing and approval of several abuse-deterrent opioid formulations.

Prior to Purdue, Dr. Baumgartner led global regulatory policy, intelligence and labeling at AstraZeneca (NASDAQ: AZN). Before his tenure at AstraZeneca, he spent more than 15 years at Bristol-Myers Squibb (NYSE: BMY) in roles of increasing seniority in clinical research and regulatory affairs, including roles as medical director for Australia/New Zealand. This was followed by regulatory roles overseeing the infectious diseases, endocrine, and metabolism portfolios, contributing to the approval and lifecycle for multiple therapies. Ultimately, he led an international regulatory team across a region comprising 46 markets including: Canada, Latin America and Asia Pacific.

Dr. Baumgartner completed his bachelor’s degree at Duke University, his medical degree at University of Missouri-Columbia and his Master in Public Health at University of California, Berkeley.